Bryopetris Pharmaceuticals Private Limited

Bryopetris Pharmaceuticals Private Limited - education in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24290MP2020PTC052620 Incorporated 02 September 2020 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company education MSME · Micro
Data last updated
Revenue · FY 2025
₹9.86 Lakh
▲ 1% YoY
Net profit · FY 2025
₹16,740
Net margin 1.7%
EBITDA · FY 2025
₹23,914
EBITDA margin 2.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Bryopetris Pharmaceuticals Private Limited

Data last updated:

Bryopetris Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the vocational and skill development training segment of the education sector. It was incorporated on 02 September 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2020PTC052620. Its GSTIN is 09AAJCB2382C1ZT (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Alok Trivedi and Roopali Trivedi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Om Parkash 288 Bhagirath Pura Near Sai Temple, Indore, Madhya Pradesh, India – 452003.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.86 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹16,740 (net margin 1.7%) and EBITDA of ₹23,914 (EBITDA margin 2.4%).

Bryopetris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0003180).

Company details

CIN U24290MP2020PTC052620
Registration Number 052620
Incorporation Date 02 September 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0003180

Recognitions & Rankings of Bryopetris Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-MP-23-0003180

Contact details

Bryopetris Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C/O Om Parkash 288 Bhagirath Pura Near Sai Temple, Indore, Madhya Pradesh, India – 452003
  • Industry
    Education, Vocational & Skill Development Training

To see the full contact details of Bryopetris Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Bryopetris Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Bryopetris Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Bryopetris Pharmaceuticals Private Limited, buy the company report.

Financials of Bryopetris Pharmaceuticals Private Limited

FY 2025 filings available

Bryopetris Pharmaceuticals Private Limited reported revenue of ₹9.86 Lakh (up 1% YoY) for FY 2025.

Revenue · FY 2025
₹9.86 Lakh ▲ 1%
Net profit · FY 2025
₹16,740 margin 1.7%
EBITDA · FY 2025
₹23,914 margin 2.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 1%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 35%

Revenue rose 1% in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹23,914
Profit Before Tax
Tax Expense
Net Profit (PAT)₹16,740
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.4%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bryopetris Pharmaceuticals Private Limited, buy the company report.

Board of directors of Bryopetris Pharmaceuticals Private Limited

Bryopetris Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Alok TrivediDirector02 Sep 20206 Years 2 MonthsCurrent
Roopali TrivediDirector27 Nov 20232 Years 11 MonthsCurrent

Auditor

Bryopetris Pharmaceuticals Private Limited is audited by JK YADAV & COMPANY for the financial year 2022.

Auditor firmFinancial yearFirm registration number
JK YADAV & COMPANYFY 2022025524C

Shareholding

The shareholding of Bryopetris Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bryopetris Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bryopetris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Bryopetris Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 28, 2024.

Active EPFO establishments
1

GST

Bryopetris Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAJCB2382C1ZTUttar PradeshActive05 Oct 2020

To see the full GST registrations and return filing status of Bryopetris Pharmaceuticals Private Limited, buy the company report.

Recent activity

Bryopetris Pharmaceuticals Private Limited has 8 board changes on record since 2020: 5 appointments and 3 cessations. The latest: Neetu Dwivedi ceased to be Additional Director on 27 Nov 2023.

AGM
Bryopetris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bryopetris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Neetu Dwivedi ceased to be Additional Director.
Appointed
Roopali Trivedi was appointed as Director.
Appointed
Neetu Dwivedi was appointed as Additional Director.
Ceased
Sumit Mehrotra ceased to be Director.
Ceased
Anoop Dwivedi ceased to be Director.
Appointed
Alok Trivedi was appointed as Director.
Appointed
Anoop Dwivedi was appointed as Director.
Appointed
Sumit Mehrotra was appointed as Director.
Incorporation
02 Sep 2020
Bryopetris Pharmaceuticals Private Limited was registered on 02 Sep 2020 with Roc Gwalior & aged 6 years 2 months as per MCA records.

Frequently asked questions

Bryopetris Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in vocational and skill development training, within the education industry. It was incorporated on 02 September 2020 (6+ years old) and is registered under CIN U24290MP2020PTC052620.

Bryopetris Pharmaceuticals has 2 current directors:

The latest financial statements of Bryopetris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Bryopetris Pharmaceuticals is 09AAJCB2382C1ZT, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Bryopetris Pharmaceuticals is U24290MP2020PTC052620. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bryopetris Pharmaceuticals was incorporated on 02 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.

Neetu Dwivedi ceased to be Additional Director on 27 Nov 2023. Roopali Trivedi was appointed as Director on 27 Nov 2023. Neetu Dwivedi was appointed as Additional Director on 22 Jan 2022. Bryopetris Pharmaceuticals has 8 board changes on record in total.

Yes, Bryopetris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0003180).

The registered office of Bryopetris Pharmaceuticals is at CO Om Parkash 288 Bhagirath Pura Near Sai Temple, Indore, Madhya Pradesh, India – 452003.

Bryopetris Pharmaceuticals operates in the education industry, in the vocational and skill development training segment.